Allogenic Plasma Eye Drops for Ligneous Conjunctivitis
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial uses eye drops made from donated blood plasma to treat patients with a rare eye condition called ligneous conjunctivitis. The eye drops provide a missing protein that helps dissolve harmful build-up on the eyes.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
Is it safe to use allogenic plasma eye drops for ligneous conjunctivitis?
How does the treatment Allogenic Plasma Aliquots differ from other treatments for ligneous conjunctivitis?
Allogenic Plasma Aliquots, used as eye drops, are unique because they involve using plasma from donors to treat ligneous conjunctivitis, a rare eye condition. This approach is different from other treatments like heterologous serum or fresh frozen plasma, as it specifically uses plasma components to potentially address the underlying issues related to the condition.12467
What data supports the effectiveness of the treatment Allogenic Plasma Aliquots for ligneous conjunctivitis?
Who Is on the Research Team?
Dorothy V Bautista, MD
Principal Investigator
Memorial University of Newfoundland
Are You a Good Fit for This Trial?
This trial is for individuals diagnosed with ligneous conjunctivitis, a rare eye condition, who have Type 1 plasminogen deficiency. It's not suitable for those with other concurrent eye diseases that would interfere with the treatment.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive allogenic plasma aliquots as eye drops to treat recurrences of ligneous conjunctivitis
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Allogenic Plasma Aliquots
Find a Clinic Near You
Who Is Running the Clinical Trial?
Dorothy Bautista, MD
Lead Sponsor
Canadian Blood Services
Collaborator